Search Results - "McInnes, Iain B"
-
1
Pathogenetic insights from the treatment of rheumatoid arthritis
Published in The Lancet (British edition) (10-06-2017)“…Summary Rheumatoid arthritis is a chronic autoimmune disease that causes progressive articular damage, functional loss, and comorbidity. The development of…”
Get full text
Journal Article -
2
JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
Published in Rheumatology (Oxford, England) (01-02-2019)“…Abstract Janus kinase (JAK)/signal transducers and activators of transcription (STATs) are a group of molecules associated with one of the major pathways…”
Get full text
Journal Article -
3
Cytokines in rheumatoid arthritis — shaping the immunological landscape
Published in Nature reviews. Rheumatology (01-01-2016)“…The contributions of key cytokines in rheumatoid arthritis (RA) pathogenesis, including TNF, IL-1, JAK-dependent cytokines, GM-CSF and chemokines, can be…”
Get full text
Journal Article -
4
Rheumatoid arthritis and depression: an inflammatory perspective
Published in The Lancet. Psychiatry (01-02-2019)“…The coexistence of immune-mediated inflammatory diseases with depression has long been recognised. Data that illustrate the intimate associations between…”
Get full text
Journal Article -
5
The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies
Published in Annals of the rheumatic diseases (01-09-2019)“…Although the pathogenic mechanisms underlying axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) are not fully elucidated, several lines of evidence…”
Get more information
Journal Article -
6
Future therapeutic targets in rheumatoid arthritis?
Published in Seminars in immunopathology (01-06-2017)“…Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by persistent joint inflammation. Without adequate treatment, patients with RA will…”
Get full text
Journal Article -
7
Cytokines in the pathogenesis of rheumatoid arthritis
Published in Nature Reviews: Immunology (01-06-2007)“…Cytokines regulate a broad range of inflammatory processes that are implicated in the pathogenesis of rheumatoid arthritis. In rheumatoid joints, it is well…”
Get full text
Journal Article -
8
Cardiometabolic comorbidities in RA and PsA: lessons learned and future directions
Published in Nature reviews. Rheumatology (01-08-2019)“…Cardiometabolic comorbidities present a considerable burden for patients with rheumatoid arthritis (RA) or psoriatic arthritis (PsA). Both RA and PsA are…”
Get full text
Journal Article -
9
Inflammatory mechanisms in tendinopathy – towards translation
Published in Nature reviews. Rheumatology (01-02-2017)“…Key Points Tendinopathy is a complex multi-faceted tendon pathology commonly associated with overuse Most current treatments for tendinopathy are neither…”
Get full text
Journal Article -
10
The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
Published in Annual review of medicine (01-01-2015)“…The Janus kinase (JAK)-signal transducer of activators of transcription (STAT) pathway is now recognized as an evolutionarily conserved signaling pathway…”
Get full text
Journal Article -
11
COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options
Published in Cardiovascular research (01-08-2020)“…Abstract The novel coronavirus disease (COVID-19) outbreak, caused by SARS-CoV-2, represents the greatest medical challenge in decades. We provide a…”
Get full text
Journal Article -
12
Why did IL-23p19 inhibition fail in AS: a tale of tissues, trials or translation?
Published in Annals of the rheumatic diseases (01-08-2019)Get more information
Journal Article -
13
Therapeutic Targeting of IL-17 and IL-23 Cytokines in Immune-Mediated Diseases
Published in Annual review of medicine (14-01-2016)“…The discovery of the biological functions of the interleukin-23 -17 axis led to the identification of IL-23 and IL-17 as important participants in the…”
Get full text
Journal Article -
14
Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis
Published in The New England journal of medicine (01-04-2021)“…In a trial comparing the JAK inhibitor upadacitinib (15 or 30 mg daily) with placebo and with the TNF-α inhibitor adalimumab, the percentage of patients with…”
Get full text
Journal Article -
15
Disease-associated functions of IL-33: the new kid in the IL-1 family
Published in Nature reviews. Immunology (01-02-2010)“…Key Points Interleukin-33 (IL-33) is a newly described member of the IL-1 cytokine family. IL-33 is expressed by endothelial cells, fibroblasts and neuronal…”
Get full text
Journal Article -
16
Tendon and ligament mechanical loading in the pathogenesis of inflammatory arthritis
Published in Nature reviews. Rheumatology (01-04-2020)“…Mechanical loading is an important factor in musculoskeletal health and disease. Tendons and ligaments require physiological levels of mechanical loading to…”
Get full text
Journal Article -
17
MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis
Published in Frontiers in immunology (05-01-2018)“…MicroRNAs (miRNAs) are small non-coding RNAs that fine-tune the cell response to a changing environment by modulating the cell transcriptome. miR-155 is a…”
Get full text
Journal Article -
18
Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
Published in The Lancet (British edition) (19-09-2015)“…Summary Background Interleukin 17A is a proinflammatory cytokine that is implicated in the pathogenesis of psoriatic arthritis. We assessed the efficacy and…”
Get full text
Journal Article -
19
Comparison of baricitinib, upadacitinib, and tofacitinib mediated regulation of cytokine signaling in human leukocyte subpopulations
Published in Arthritis research & therapy (02-08-2019)“…The in vitro pharmacology of baricitinib, upadacitinib, and tofacitinib was evaluated to understand differences among these JAK inhibitors (JAKis) at the…”
Get full text
Journal Article -
20
Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3)
Published in Arthritis research & therapy (15-03-2018)“…The study aimed to assess 52-week efficacy and safety of secukinumab self-administration by autoinjector in patients with active psoriatic arthritis (PsA) in…”
Get full text
Journal Article